Merit Medical Systems Inc. (MMSI)
MMSI trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/856982/000085698226000008/0000856982-26-000008-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | MMSI on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000856982 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | UT |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.5B |
| Net income | $128.5M |
| Operating income | $184.7M |
| Net margin | 8.5% |
| Operating margin | 12.2% |
| Revenue growth | +11.8% |
| Cash | $446.4M |
| Total assets | $2.7B |
| P/E (computed) | 40.3× |
| P/S (computed) | 3.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-10-29 |
| Cash and burn | $503.6M cash; operating cash flow $68.4M a quarter. | Report 2026-09-30 |
| Shares outstanding | 59,915,044 (2026-10-27); 59,290,248 a year earlier; 57,750,462 three years earlier. | Cover page 2026-10-27 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, Salt Lake City, Utah, United States | PCAOB Form AP 2026-03-12 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $573K, sold $8.5M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $416.2M | $42.3M | $65.3M | $503.6M | $737.4M | $1.6B | 10-Q 2026-10-29 |
| Q2 2026 2026-06-30 | $418.8M | $38.8M | $69.3M | $448.7M | $736.3M | $1.6B | 10-Q 2026-07-30 |
| Q1 2026 2026-03-31 | $381.9M | $41.0M | $40.7M | $488.1M | $735.2M | $1.5B | 10-Q 2026-04-30 |
| Q4 2025 2025-12-31 | $393.9M | $38.0M | $98.5M | $446.4M | $734.0M | $1.5B | 10-K 2026-02-24 |
| Q3 2025 2025-09-30 | $384.2M | $27.8M | $75.0M | $392.5M | $732.9M | $1.5B | 10-Q 2026-10-29 |
| Q2 2025 2025-06-30 | $382.5M | $32.6M | $83.3M | $341.8M | $731.8M | $1.4B | 10-Q 2026-07-30 |
| Q1 2025 2025-03-31 | $355.4M | $30.1M | $40.6M | $395.5M | $730.7M | $1.4B | 10-Q 2026-04-30 |
| Q4 2024 2024-12-31 | $355.2M | $27.9M | $68.7M | $376.7M | $729.6M | $1.4B | 10-K 2026-02-24 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2018-07-26 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-10-29 |
| Latest current report | 8-K | 2026-10-29 |
| Latest proxy | DEFA14A | 2026-03-31 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.7% |
| 1 month | -1.7% |
| 3 months | -4.3% |
| Year to date | -1.7% |
| 1 year | -0.9% |
| From 52-week high | -8.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MMED | MiniMed Group Inc. | $18.65 | +3.67% | $5.2B |
| HAE | Haemonetics Corporation | $121.34 | -1.30% | $5.5B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
| TFX | Teleflex Incorporated | $157.10 | +1.51% | $6.2B |
| STVN | Stevanato Group S.p.A. | $15.53 | -1.71% | $4.2B |
| HTFL | Heartflow Inc. | $46.86 | -3.30% | $4.1B |
| NVST | Envista Holdings Corporation | $24.03 | -1.88% | $3.9B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $46.36 | -8.09% | $3.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier